Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne A Betts

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|November 13, 2012
Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophyCorinne A Betts, Matthew J A Wood
Molecules (Basel, Switzerland)|May 20, 2015
Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophyTirsa L E van Westering, Corinne A Betts, Matthew J A Wood
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing tissue-specific antisense oligonucleotide-peptide conjugatesCorinne A Betts, Suzan M Hammond, Hai-Fang Yin, et al.
Biological Procedures Online|March 18, 2014
Detection and quantification of extracellular microRNAs in murine biofluidsThomas C Roberts, Anna M L Coenen-Stass, Corinne A Betts, et al.
Advanced Drug Delivery Reviews|March 10, 2015
Delivery of therapeutic oligonucleotides with cell penetrating peptidesPrisca Boisguérin, Sébastien Deshayes, Michael J Gait, et al.
Scientific Reports|December 20, 2016
Corrigendum: Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomicsAnna M L Coenen-Stass, Graham McClorey, Raquel Manzano, et al.
Scientific Reports|November 24, 2015
Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomicsAnna M L Coenen-Stass, Graham McClorey, Raquel Manzano, et al.
Human Molecular Genetics|July 29, 2016
Selective release of muscle-specific, extracellular microRNAs during myogenic differentiationAnna M L Coenen-Stass, Corinne A Betts, Yi F Lee, et al.
Plos One|June 19, 2018
Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophyAlison M Blain, Elizabeth Greally, Graham McClorey, et al.
Human Molecular Genetics|July 9, 2018
Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy miceLisa M Walter, Christiane E Koch, Corinne A Betts, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|November 13, 2012
Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophyCorinne A Betts, Matthew J A Wood
Molecules (Basel, Switzerland)|May 20, 2015
Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophyTirsa L E van Westering, Corinne A Betts, Matthew J A Wood
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing tissue-specific antisense oligonucleotide-peptide conjugatesCorinne A Betts, Suzan M Hammond, Hai-Fang Yin, et al.
Biological Procedures Online|March 18, 2014
Detection and quantification of extracellular microRNAs in murine biofluidsThomas C Roberts, Anna M L Coenen-Stass, Corinne A Betts, et al.
Advanced Drug Delivery Reviews|March 10, 2015
Delivery of therapeutic oligonucleotides with cell penetrating peptidesPrisca Boisguérin, Sébastien Deshayes, Michael J Gait, et al.
Scientific Reports|December 20, 2016
Corrigendum: Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomicsAnna M L Coenen-Stass, Graham McClorey, Raquel Manzano, et al.
Scientific Reports|November 24, 2015
Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomicsAnna M L Coenen-Stass, Graham McClorey, Raquel Manzano, et al.
Human Molecular Genetics|July 29, 2016
Selective release of muscle-specific, extracellular microRNAs during myogenic differentiationAnna M L Coenen-Stass, Corinne A Betts, Yi F Lee, et al.
Plos One|June 19, 2018
Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophyAlison M Blain, Elizabeth Greally, Graham McClorey, et al.
Human Molecular Genetics|July 9, 2018
Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy miceLisa M Walter, Christiane E Koch, Corinne A Betts, et al.
Pageof 2